https://vilgelmlab.owlstown.net https://vilgelmlab.owlstown.net/publications https://vilgelmlab.owlstown.net/projects https://vilgelmlab.owlstown.net/people https://vilgelmlab.owlstown.net/courses https://vilgelmlab.owlstown.net/posts https://vilgelmlab.owlstown.net/pages https://vilgelmlab.owlstown.net/cv https://vilgelmlab.owlstown.net/contact_form https://vilgelmlab.owlstown.net/publications/8390-personalized-cancer-immunotherapy https://vilgelmlab.owlstown.net/publications/8389-treatment-with-soluble-cd24-attenuates-covid-19-associated-systemic-immunopathology https://vilgelmlab.owlstown.net/publications/8395-cell-therapy-with-tils-training-and-taming-t-cells-to-fight-cancer https://vilgelmlab.owlstown.net/publications/8394-a-pilot-phase-i-trial-of-il-21-expanded-ideal-donor-natural-killer-nk-cells-in-combination-with-mogamulizumab-in-patients-with-cutaneous-t-cell-lymphomas-ctcl-or-adult-t-cell-leukemia-lymphomas-atll https://vilgelmlab.owlstown.net/publications/8396-abstract-1578-heating-it-up-targeting-ras-raf-pi3k-pathway-to-make-melanoma-tumors-immunologically-hot-and-suitable-for-checkpoint-blockade-immunotherapies https://vilgelmlab.owlstown.net/publications/8397-novel-induction-of-cd40-expression-by-tumor-cells-with-ras-raf-pi3k-pathway-inhibition-augments-response-to-checkpoint-blockade https://vilgelmlab.owlstown.net/publications/8391-immunological-insights-into-the-therapeutic-roles-of-cd24fc-against-severe-covid-19 https://vilgelmlab.owlstown.net/publications/8393-treatment-with-soluble-cd24-attenuates-covid-19-associated-systemic-immunopathology https://vilgelmlab.owlstown.net/publications/8392-metabolic-modulation-by-cdk4-6-inhibitor-promotes-chemokine-mediated-recruitment-of-t-cells-into-mammary-tumors https://vilgelmlab.owlstown.net/publications/8398-abstract-1054-patient-derived-organoids-demonstrate-synergistic-antitumor-effect-of-senogenic-and-senolytic-drug-combination-of-aurora-kinase-inhibitor-and-bcl2-xl-inhibitor https://vilgelmlab.owlstown.net/publications/8404-fine-needle-aspiration-based-patient-derived-cancer-organoids https://vilgelmlab.owlstown.net/publications/8405-correlative-studies-investigating-effects-of-pi3k-inhibition-on-peripheral-leukocytes-in-metastatic-breast-cancer-potential-implications-for-immunotherapy https://vilgelmlab.owlstown.net/publications/8399-obtaining-patient-derived-cancer-organoid-cultures-via-fine-needle-aspiration https://vilgelmlab.owlstown.net/publications/8408-fine-needle-aspiration-use-in-organoid-research https://vilgelmlab.owlstown.net/publications/8400-targeted-deletion-of-cxcr2-in-myeloid-cells-alters-the-tumor-immune-environment-to-improve-antitumor-immunity https://vilgelmlab.owlstown.net/publications/8406-high-throughput-drug-screening-of-fine-needle-aspiration-derived-cancer-organoids https://vilgelmlab.owlstown.net/publications/8403-co-clinical-imaging-resource-program-cirp-bridging-the-translational-divide-to-advance-precision-medicine https://vilgelmlab.owlstown.net/publications/8407-metastatic-melanoma-patient-derived-xenografts-respond-to-mdm2-inhibition-as-a-single-agent-or-in-combination-with-braf-mek-inhibition https://vilgelmlab.owlstown.net/publications/8402-abstract-b20-patient-derived-organoids-demonstrate-synergistic-effect-of-co-targeting-aurora-kinase-and-prosurvival-bcl2-family-proteins https://vilgelmlab.owlstown.net/publications/8401-correction-to-multimodal-multiplexed-immunoimaging-with-nanostars-to-detect-multiple-immunomarkers-and-monitor-response-to-immunotherapies https://vilgelmlab.owlstown.net/publications/8409-abstract-2552-senescence-induced-by-cdk4-6-inhibition-facilitates-anti-tumor-t-cell-responses https://vilgelmlab.owlstown.net/publications/8410-chemokines-modulate-immune-surveillance-in-tumorigenesis-metastasis-and-response-to-immunotherapy https://vilgelmlab.owlstown.net/publications/8412-mdm2-antagonists-overcome-intrinsic-resistance-to-cdk4-6-inhibition-by-inducing-p21 https://vilgelmlab.owlstown.net/publications/8411-multimodal-multiplexed-immunoimaging-with-nanostars-to-detect-multiple-immunomarkers-and-monitor-response-to-immunotherapies https://vilgelmlab.owlstown.net/publications/8413-abstract-4948-mdm2-antagonism-overcomes-resistance-to-cdk4-6-inhibition-in-melanoma https://vilgelmlab.owlstown.net/publications/8414-loss-of-cxcr4-in-myeloid-cells-enhances-antitumor-immunity-and-reduces-melanoma-growth-through-nk-cell-and-fasl-mechanisms https://vilgelmlab.owlstown.net/publications/8415-abstract-b166-investigating-the-effect-of-cdk4-6-and-mdm2-inhibition-on-melanoma https://vilgelmlab.owlstown.net/publications/8416-abstract-607-inhibition-of-cdk4-6-and-pi3k-modulates-mammary-tumor-immune-microenvironment-to-enhance-response-to-immunotherapy https://vilgelmlab.owlstown.net/publications/8417-abstract-513-the-link-between-polyploidy-and-replication-stress-in-melanoma https://vilgelmlab.owlstown.net/publications/8418-mdm2-antagonists-counteract-drug-induced-dna-damage https://vilgelmlab.owlstown.net/publications/8423-using-avatars-to-win-the-fight-over-braf-inhibitor-resistance https://vilgelmlab.owlstown.net/publications/8422-connecting-the-dots-therapy-induced-senescence-and-a-tumor-suppressive-immune-microenvironment https://vilgelmlab.owlstown.net/publications/8424-abstract-5126-the-link-between-therapy-induced-senescence-and-anti-tumor-immune-microenvironment-in-melanoma https://vilgelmlab.owlstown.net/publications/8420-combinatorial-approach-to-cancer-immunotherapy-strength-in-numbers https://vilgelmlab.owlstown.net/publications/8419-melanoma-specific-mhc-ii-expression-represents-a-tumour-autonomous-phenotype-and-predicts-response-to-anti-pd-1-pd-l1-therapy https://vilgelmlab.owlstown.net/publications/8421-pi3k-inhibition-reduces-mammary-tumor-growth-and-facilitates-antitumor-immunity-and-anti-pd1-responses https://vilgelmlab.owlstown.net/publications/8428-combined-therapies-that-induce-senescence-and-stabilize-p53-block-melanoma-growth-and-prompt-antitumor-immune-responses https://vilgelmlab.owlstown.net/publications/8427-abstract-b12-synergistic-anticancer-activity-of-aurora-a-kinase-and-mdm2-antagonists-in-melanoma https://vilgelmlab.owlstown.net/publications/8426-mdm2-and-aurora-kinase-a-inhibitors-synergize-to-block-melanoma-growth-by-driving-apoptosis-and-immune-clearance-of-tumor-cells https://vilgelmlab.owlstown.net/publications/8425-combining-an-aurora-kinase-inhibitor-and-a-death-receptor-ligand-agonist-antibody-triggers-apoptosis-in-melanoma-cells-and-prevents-tumor-growth-in-preclinical-mouse-models https://vilgelmlab.owlstown.net/publications/8429-engineered-three-dimensional-microfluidic-device-for-interrogating-cell-cell-interactions-in-the-tumor-microenvironment https://vilgelmlab.owlstown.net/publications/8430-preparation-of-nutlin-3-using-enantioselective-organocatalysis-at-decagram-scale https://vilgelmlab.owlstown.net/publications/8431-preparation-of-nutlin-3-using-enantioselective-organocatalysis-at-decagram-scale https://vilgelmlab.owlstown.net/publications/8433-abstract-5602-molecular-mechanism-underlying-acquired-resistance-to-aurora-a-kinase-inhibitor-alisertib-in-melanoma https://vilgelmlab.owlstown.net/publications/8432-targeting-aurora-kinases-limits-tumour-growth-through-dna-damage-mediated-senescence-and-blockade-of-nf-b-impairs-this-drug-induced-senescence https://vilgelmlab.owlstown.net/publications/8435-cancer-therapy-preclinical-raf-265-inhibits-the-growth-of-advanced-human-melanoma-tumors https://vilgelmlab.owlstown.net/publications/8434-raf265-inhibits-the-growth-of-advanced-human-melanoma-tumors https://vilgelmlab.owlstown.net/publications/8436-coordinated-interaction-of-multifunctional-members-of-the-p53-family-determines-many-key-processes-in-multicellular-organisms https://vilgelmlab.owlstown.net/publications/8440-interactions-of-the-p53-protein-family-in-cellular-stress-response-in-gastrointestinal-tumors https://vilgelmlab.owlstown.net/publications/8439-w1754-role-of-p73-and-mechanisms-of-its-regulation-in-gastrointestinal-tumors https://vilgelmlab.owlstown.net/publications/8438-characterization-of-np73-expression-and-regulation-in-gastric-and-esophageal-tumors https://vilgelmlab.owlstown.net/publications/8437-regulation-of-p53-tumor-suppressor-by-helicobacter-pylori-in-gastric-epithelial-cells https://vilgelmlab.owlstown.net/publications/8441-683-helicobacter-pylori-actively-dysregulates-p53-tumor-suppressor https://vilgelmlab.owlstown.net/publications/8442-w1921-interactions-within-the-p53-protein-family-play-critical-role-in-cancer-chemotherapeutic-treatment-new-insights-into-chemotherapeutic-drug-response-in-gastrointestinal-tumors https://vilgelmlab.owlstown.net/publications/8443-deltanp73alpha-regulates-mdr1-expression-by-inhibiting-p53-function https://vilgelmlab.owlstown.net/publications/8444-np73-regulates-mdr1-expression-by-inhibiting-p53-function https://vilgelmlab.owlstown.net/publications/8446-therapeutic-prospects-for-p73-and-p63-rising-from-the-shadow-of-p53 https://vilgelmlab.owlstown.net/publications/8445-interaction-of-helicobacter-pylori-with-gastric-epithelial-cells-is-mediated-by-the-p53-protein-family https://vilgelmlab.owlstown.net/publications/8447-lentiviral-vectors https://vilgelmlab.owlstown.net/publications/8449-rna-interference-biology-and-prospects-of-application-in-biomedicine-and-biotechnology https://vilgelmlab.owlstown.net/publications/8448-akt-mediated-phosphorylation-and-activation-of-estrogen-receptor-alpha-is-required-for-endometrial-neoplastic-transformation-in-pten-mice https://vilgelmlab.owlstown.net/publications/8450-the-gastrin-gene-promoter-is-regulated-by-p73-isoforms-in-tumor-cells